Fertility and Sterility
Volume 90, Issue 3 , Pages 699-708 , September 2008

Low-density lipoprotein receptor–related protein-5 C/T polymorphism in exon 18 is associated with C peptide and proinsulin levels in control women and patients with polycystic ovary syndrome

  • Bela Bendlova, M.Sc., Ph.D.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • Corresponding Author InformationReprint requests: Bela Bendlova, M.Sc., Ph.D., Institute of Endocrinology, Narodni 8, Prague 1, 11694, Czech Republic (FAX: 420224-905-235).
    • ,
  • Marketa Vankova, M.Sc., Ph.D.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Katerina Zajickova, M.D., Ph.D.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Martin Hill, D.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Adela Zemanova, M.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • David Cibula, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Charles University, Prague, Czech Republic
    • ,
  • Daniela Vejrazkova, M.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Petra Lukasova, M.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Josef Vcelak, M.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Karel Vondra, M.D., D.Sc.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic
    • ,
  • Jana Vrbikova, M.D., Ph.D.

      Affiliations

    • Institute of Endocrinology, Charles University, Prague, Czech Republic

Received 15 December 2006 ,Revised 25 June 2007 ,Accepted 25 June 2007.

References 

  1. Cibula D. Is insulin resistance an essential component of PCOS? The influence of confounding factors. Hum Reprod. 2004;19:757–759
  2. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995;96:520–527
  3. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994;78:1052–1058
  4. Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1995;80:2586–2593
  5. Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG. beta-Cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:310–315
  6. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993;76:1241–1247
  7. Vankova M, Vrbikova J, Hill M, Cinek O, Bendlova B. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann NY Acad Sci. 2002;967:558–565
  8. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care. 2002;25:1217–1222
  9. Elbein SC, Hasstedt SJ, Wegner K, Kahn SE. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab. 1999;84:1398–1403
  10. Hey PJ, Twells RC, Phillips MS, Yusuke N, Brown SD, Kawaguchi Y, et al. Cloning of a novel member of the low-density lipoprotein receptor family. Gene. 1998;216:103–111
  11. Figueroa DJ, Hess JF, Ky B, Brown SD, Sandig V, Hermanowski-Vosatka A, et al. Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes. J Histochem Cytochem. 2000;48:1357–1368
  12. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD, et al. Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr. 2003;11:141–147
  13. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, Takada S, et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci USA. 2003;100:229–234
  14. Kanazawa A, Tsukada S, Sekine A, Tsunoda T, Takahashi A, Kashiwagi A, et al. Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. Am J Hum Genet. 2004;75:832–843
  15. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev. 2001;15:111–127
  16. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM, Strauss JF. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol. 2004;63:51–60
  17. He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131:1663–1677
  18. Koay MA, Brown MA. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol Med. 2005;11:129–137
  19. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, et al. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res. 2004;19:1619–1627
  20. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9:505–514
  21. Vrbikova J, Cibula D, Dvorakova K, Stanicka S, Sindelka G, Hill M, et al. Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:2942–2945
  22. Okubo M, Horinishi A, Kim DH, Yamamoto TT, Murase T. Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene. Hum Mutat. 2002;19:186
  23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  24. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470
  25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223
  26. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  27. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26:251–282
  28. Fratantonio E, Vicari E, Pafumi C, Calogero AE. Genetics of polycystic ovarian syndrome. Reprod Biomed Online. 2005;10:713–720
  29. Pugliese A, Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev. 2002;8:13–25
  30. Huxtable SJ, Saker PJ, Haddad L, Walker M, Frayling TM, Levy JC, et al. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes. 2000;49:126–130
  31. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 2003;52:568–572
  32. Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol. 2006;38:873–893
  33. Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev. 2005;21:495–504
  34. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology. 2005;146:1025–1034
  35. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34:207–216
  36. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes. 2006;55:2903–2908
  37. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–323
  38. Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet. 1997;349:986–990
  39. Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, et al. Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf). 2001;55:439–446
  40. Calvo RM, Telleria D, Sancho J, San Millan JL, Escobar-Morreale HF. Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril. 2002;77:666–668
  41. Powell BL, Haddad L, Bennett A, Gharani N, Sovio U, Groves CJ, et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. J Clin Endocrinol Metab. 2005;90:2988–2993
  42. Cobelli C, Pacini G. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes. 1988;37:223–231
  43. Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001;281:E966–E974

 Supported by grants of the Grant Agency of the Czech Republic 301/04/1085 and Internal Grant Agency of the Ministry of Health of the Czech Republic NR/7809-5 and 8759-3.

 Presented in part at the conjoint American Society for Reproductive Medicine and Canadian Fertility and Andrology Society meeting, Montreal, Canada, October 15–19, 2005.

PII: S0015-0282(07)01430-6

doi: 10.1016/j.fertnstert.2007.06.076

Fertility and Sterility
Volume 90, Issue 3 , Pages 699-708 , September 2008

Article Tools

* Image Usage & Resolution